Status:
COMPLETED
Tolerance of Chlorhexidine Gluconate Vaginal Cleansing Solution
Lead Sponsor:
Northwestern University
Conditions:
Surgical Preparation of the Vagina
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Conduct a randomized control study to compare the tolerance of 4% chlorhexidine gluconate/4% isopropyl alcohol versus povidone iodine vaginal cleansing solutions for surgical preparations of the vagin...
Detailed Description
Surgical site antisepsis is critical in preventing surgical site infections. Although chlorhexidine gluconate has proven to be superior to povidone iodine for surgical site antisepsis, povidone iodine...
Eligibility Criteria
Inclusion
- Undergoing hysteroscopy
- Gynecologic dilation \& curettage
- Endometrial ablation
- Essure without concomitant laparoscopy
Exclusion
- Pregnant
- Have a history of atopic dermatitis, vaginal irritation, allergic reactions, or anaphylaxis to chlorhexidine gluconate or povidone iodine.
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2018
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT03305159
Start Date
August 1 2017
End Date
April 15 2018
Last Update
June 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prentice Women's Hospital - Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611